Baxter International Inc. (bax)
BAX — Company Overview
Investors tracking BAX follow a Medical Instruments & Supplies name listed on NYQ within Healthcare.
| Ticker | BAX |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Exchange | NYQ |
| Market cap | $12.14B |
| Last price | $23.49 |
| Size category | Large Cap |
BAX — Business Description
The business profile of Baxter International Inc. (BAX) reflects its role in Medical Instruments & Supplies. Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices,…
Official website: https://www.baxter.com.
BAX — Investment Thesis
Baxter International Inc. (BAX) attracts investors weighing Medical Instruments & Supplies fundamentals against current market pricing.
- Revenue is expanding at roughly 5.3% year-over-year (public data).
- Equity market capitalization is approximately $12.14B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
BAX — Financial Health
BAX financial profile reflects operating efficiency and capital structure using available market fundamentals.
Negative profit margin (-9.3%) signals near-term profitability pressure. Positive free cash flow of $1.00B supports balance-sheet flexibility. Debt-to-equity of 156.45 warrants monitoring in a higher-rate environment.
| Forward P/E | 11.54× |
| Price / Sales | 1.06× |
| Price / Book | 1.96× |
| Gross margin | 34.1% |
| Operating margin | 14.4% |
| Profit margin | -9.3% |
| Return on equity | -14.4% |
| Debt / Equity | 156.45 |
| Free cash flow | $1.00B |
BAX — Growth Outlook
Growth outlook for Baxter International Inc. (BAX) depends on demand trends in Medical Instruments & Supplies and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 5.3% suggests steady but measured expansion.
- Earnings growth of 36.8% year-over-year supports improving profitability.
- Price is 21.7% below the 52-week high.
BAX — Competitive Position
Baxter International Inc. (BAX) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Instruments & Supplies.
- Market capitalization of $12.14B places BAX among large-cap peers.
- Gross margin of 34.1% should be benchmarked against direct competitors.
BAX — Strengths
Strengths for Baxter International Inc. (BAX) inferred from public financial metrics:
- Revenue growth of 5.3% year-over-year.
- Earnings growth of 36.8% year-over-year.
- Positive free cash flow ($1.00B).
- Large Cap scale ($12.14B) may provide distribution and funding advantages.
BAX — Weaknesses
Weaknesses and pressure points for Baxter International Inc. (BAX) based on available data:
- Thin profit margin (-9.3%).
- Elevated debt-to-equity (156.45).
BAX — Opportunities
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
BAX — Risks
- Leverage (debt/equity 156.45) raises sensitivity to credit conditions.
- Thin margins leave less room for operational missteps.
BAX — Summary
Baxter International Inc. (BAX) is a large-cap Healthcare company focused on Medical Instruments & Supplies, listed on NYQ. Last price $23.49 with market cap $12.14B. Revenue grew 5.3% year-over-year per public data. Notable strengths include revenue growth of 5.3% year-over-year. Key watch items include thin profit margin (-9.3%). Review free estimates and earnings pages for BAX; upgrade for institutional ownership and live headlines.
Start Free — open BAX in Vest Terminal
Access live data, filings, ownership, and analysis for Baxter International Inc..
Baxter International Inc. FAQ
What does Baxter International Inc. (BAX) do?
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous…
What is BAX's P/E ratio?
Baxter International Inc. has a trailing P/E of N/A× based on publicly available market data.
Does BAX pay a dividend?
Indicated dividend yield: 0.2%. Confirm ex-dates and payout history in Vest Terminal.
What sector is BAX in?
Baxter International Inc. is classified in Healthcare (Medical Instruments & Supplies) on NYQ.
What is BAX's market capitalization?
Approximate market cap: $12.14B.
What are the main risks for BAX?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of BAX?
Potential positives include revenue growth of 5.3% year-over-year, earnings growth of 36.8% year-over-year.
Where can I get analyst estimates for BAX?
Public analyst price targets and consensus for Baxter International Inc. are on the free /stocks/bax/estimates page. Deeper estimate history and models are available in Vest Terminal.